---
search:
  boost: 3
---

# Inhaled

This is a subcategory of Infectious Disease Agents.

## Decision Trees

- [Antibiotics - Inhaled- Non-Preferred - Arikayce, Bethkis, Cayston, Kitabis Pak, Tobi Podhaler](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNklGMlY2WTJUTFRMWENTNkxXQVVEUUVFRyQlQCN0PWcu){ :target="_blank" rel="noopener"}

- [Antibiotics - Inhaled- Preferred - Tobramycin](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNFlXQ05YUlRLVjA2RzU0OUYwUUhHQktGVCQlQCN0PWcu){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                   | Generic Name                               |         Quantity          |        Time (Days)        |
| :-------------------------- | :----------------------------------------- | :-----------------------: | :-----------------------: |
| Tobramycin <sup>PA QL</sup> | Tobramycin Nebulizing Soln (all strengths) | Determined pursuant to PA | Determined pursuant to PA |

### Non-Preferred

| Non-Preferred                | Generic Name                               |         Quantity          |        Time (Days)        |
| :--------------------------- | :----------------------------------------- | :-----------------------: | :-----------------------: |
| Arikayce                     |                                            |                           |                           |
| Bethkis <sup> QL</sup>       | Tobramycin Nebulizing Soln (all strengths) | Determined pursuant to PA | Determined pursuant to PA |
| Cayston                      |                                            |                           |                           |
| Kitabis Pak <sup> QL</sup>   |                                            |                           |                           |
| Tobi Podhaler <sup> QL</sup> |                                            |                           |                           |

## Authorizations ==(PROCESS BY NDC)==

**Length of Authorizations**: Initial: 180 days; Subsequent 365 days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling



## Criteria

### Clinical PA

Clinical PA Criteria

- Must provide documentation of cultures demonstrating drug is prescribed in alignment with approved indication

### Non-Preferred

Non-Preferreed Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least **28 days** with at least **one preferred** drug
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring (i.e., culture conversion, symptom improvement)

**QL** - Tobramycin drugs: 56 doses in 56 days

## Links

[Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)](https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7BCD777F63-7F18-4713-8D6A-B043BEE631F5%7D&file=Denial%20Language%20Updated%2009112023.docx&action=embedview&mobileredirect=true&wdStartOn=74&cid=f4472ece-6d4f-4694-b0c5-c150a2f53fea){:target="_blank" rel="noopener"} 

[Criteria](https://medicaid.ohio.gov/static/PHM/drug-coverage/20230701+UPDL+Criteria+_v1_FINAL.approved.pdf#page=78){ :target="_blank" rel="noopener"}

[Preferred Drug List](https://medicaid.ohio.gov/static/PHM/drug-coverage/20230701_UPDL_FINAL_ODM.approved.v2.pdf#page=26){ :target="_blank" rel="noopener"}
[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf){ :target="_blank" rel="noopener"}
